Mode
Text Size
Log in / Sign up

Organ-specific metastatic niches at vascular-immune interfaces shape the fate of disseminated tumor cellsSpecific Organ Environments Shape How Cancer Spreads to New Sites

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that organ-specific niches at vascular-immune interfaces determine metastatic fate and may influence immunotherapy response.

This mini review examines the role of organ-specific metastatic niches in cancer progression. The authors synthesize evidence regarding how vascular-immune interfaces, characterized by endothelial heterogeneity and tissue-resident immunity, shape the fate of disseminated tumor cells across different organs.

Key findings indicate that specific environments dictate outcomes: lung metastasis involves a barrier formed by capillary endothelium, alveolar macrophages, and neutrophils that can switch from control to support; liver sinusoids involve Kupffer cells and macrophages that may suppress systemic immunotherapy; and bone metastasis involves specialized vessels overlapping with hematopoietic niches for immune evasion. Additionally, the blood-brain barrier's endothelial and mural-cell states interact with microglia and astrocytes to regulate tumor entry.

The authors conclude that therapeutic designs should focus on targeting specific pathogenic microdomains and transition states rather than depleting entire cell classes throughout the body. While the review highlights the complexity of these niches, the clinical application remains focused on identifying specific local interactions for targeted intervention.

How this fits prior evidence

This mini review addresses a gap in understanding how localized tissue environments influence metastatic progression. It expands upon previous evidence regarding metastasis detection by focusing on the biological mechanisms of niche-specific immune evasion and adaptation. While prior coverage noted high accuracy in detecting metastasis via imaging, this review details the underlying cellular and vascular interactions that facilitate such growth in organs like the brain.

Researchers reviewed how cancer spreads, known as metastasis, to different organs. They found that each organ has a unique environment where cancer cells must adapt to survive. These locations, called niches, are shaped by local blood vessels and specific immune cells.

In the lungs, certain cells can switch from fighting tumors to helping them grow. In the liver, specific cells might hide cancer from the body's immune system, which could make some treatments less effective. The brain and bones also have unique barriers and environments that cancer cells use to stay hidden or grow more easily.

Because these areas are so different, experts suggest that future treatments should be more precise. Instead of targeting every cell of a certain type throughout the whole body, doctors may eventually target only the specific areas where cancer is hiding. This review provides an overview of how local environments influence cancer behavior.

What this means for you:
Cancer cells adapt to different organs by interacting with unique local blood vessels and immune cells.

Common questions

Why does cancer behave differently in different organs?

Cancer behaves differently because each organ has a unique environment. For example, the liver uses specific cells to manage waste and immune tolerance, while the bone has specialized vessels that cancer cells use to hide from the immune system. These local environments shape how the cancer grows.

How do lung and liver environments affect cancer?

In the lungs, certain blood vessel cells and macrophages can switch from controlling tumors to supporting them. In the liver, specific cells like Kupffer cells can create a state of immune tolerance that might make it harder for systemic immunotherapies to work.

What is the role of blood vessels in cancer spread?

Blood vessels are critical because they form the interface where cancer cells first meet the body's immune system. The specific types of cells making up these vessels, such as those in the brain or bone, determine if a cancer cell can enter and adapt to that organ.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedAug 2026
View Original Abstract ↓
Organ-specific metastatic niches begin at vascular–immune interfaces, where endothelial heterogeneity and tissue-resident immunity shape the fate of disseminated tumor cells. Hemodynamics and vascular geometry shape initial tumor-cell encounters, whereas endothelial and perivascular immune states determine whether arrest progresses to extravasation, immune elimination, dormancy, or outgrowth. This Mini Review uses vascular–immune zonation as an organizing framework for comparing four common metastatic sites. In the lung, capillary endothelium, alveolar macrophages, and rapidly recruited neutrophils form a responsive barrier that can switch from tumor control to metastatic support. Liver sinusoids couple scavenging and immune tolerance, allowing Kupffer cells and recruited macrophages to exert stage-dependent effects that can also suppress systemic immunotherapy. At the blood–brain barrier, endothelial and mural-cell states interact with microglia and astrocytes to control entry and adaptation. In bone, specialized vessels overlap with hematopoietic and osteogenic niches that metastatic cells exploit for immune evasion and dormancy escape. Across organs, the same immune-cell label does not imply the same function because location, ontogeny, and neighboring stromal cells constrain cell state. Therapeutic design should therefore target pathogenic microdomains and transition states rather than deplete a cell class throughout the body. Spatially matched sampling of metastatic lesions, adjacent tissue, and blood will be needed to translate this site-aware model into biomarkers and combination therapies.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.